About Us
GBR is a Private entity, with its line of activities is Primarily manufacturing Active Pharmaceutical Ingredients(API’s) and an end-to-end solution provider for serious or life-threatening respiratory diseases. Our management team has significant experience to development and commercialization of Pulmonary medicine, Innovate to deliver cost effective products and services, identifying unmet needs, and integrated pulmonary drug delivery solutions. Our team has the potential to address major unmet needs associated with pulmonary disorders, chronic infection and related mucus accumulation and inflammation.
GBR has a portfolio of over 15 process patents. Our R&D team is currently focusing on the understanding of the underlying mechanisms of diseases, targeted therapy and minimize the drug dosage with maximum efficacy.
Portfolio
API's
Abediterol (P)
Aclidinium bromide (P)
Aliskiren hemifumarate
Apixaban
Batefenterol (P)
Beraprost
Dolutegravir
Epoprostenol
Glycopyrronium Bromide
Iloprost
Indicaterol (P)
Lamivudine
Lenalidomide
Mirabegron (P)
Navafenterol (P)
Olodaterol (P)
Oseltamivir phosphate
Ozanimod (P)
Revefenacin
Rivaroxaban
Roflumilast
Siponimod (P)
Solabegron (P)
Tofacitinib
Treprostinil
Umeclidinium Bromide (P)
Vilanterol (P)
Intermediates
Glycopyrronium Bromide
2-Cyclopentyl-2-hydroxy-2- phenylacetic acid
CAS No. 427-49-6
N-Methylpyrrolidin-3-ol
CAS No. 13220-33-2
N-Methylpyrrolidin-3-one
CAS No. 68165-06-0
2-Cyclopentyl-2-oxoacetic acid
CAS No. 5763-56-4
Umeclidinium Bromide
((2-Bromoethoxy)methyl)benzene
CAS No. 1462-37-9
Diphenyl(quinuclidin-4- yl)methanol
CAS No. 461648-39-5
Methyl quinuclidine-4- carboxylate
CAS No. 51069-26-2
4-Bromoquinuclidine
CAS No. 99310-70-0
Particle Engineering Technology
At GBR Laboratories Pvt Ltd, we have a dedicated team of experts with tremendous experience in API drug Manufacturing and particle engineering. Our team can provide solutions to complex formulation challenges and rapidly progress novel drugs to market. Our advanced particle engineering technology can produce Nano size particles small (10nm) enough to cross biological barriers and even penetrate into the deep lung and large enough for nasal delivery (10 microns). This technology can be vastly used to cure Respiratory/ Pulmonary Diseases.
